334 related articles for article (PubMed ID: 17562988)
21. Assessing hydroxychloroquine toxicity by the multifocal ERG.
Moschos MN; Moschos MM; Apostolopoulos M; Mallias JA; Bouros C; Theodossiadis GP
Doc Ophthalmol; 2004 Jan; 108(1):47-53. PubMed ID: 15104166
[TBL] [Abstract][Full Text] [Related]
22. Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.
Garrity ST; Jung JY; Zambrowski O; Pichi F; Su D; Arya M; Waheed NK; Duker JS; Chetrit Y; Miserocchi E; Giuffrè C; Kaden TR; Querques G; Souied EH; Freund KB; Sarraf D
Br J Ophthalmol; 2019 Nov; 103(11):1600-1604. PubMed ID: 30819690
[TBL] [Abstract][Full Text] [Related]
23. Hydroxychloroquine retinopathy: an emerging problem.
Latasiewicz M; Gourier H; Yusuf IH; Luqmani R; Sharma SM; Downes SM
Eye (Lond); 2017 Jun; 31(6):972-976. PubMed ID: 28186509
[TBL] [Abstract][Full Text] [Related]
24. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
[TBL] [Abstract][Full Text] [Related]
25. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.
Ruberto G; Bruttini C; Tinelli C; Cavagna L; Bianchi A; Milano G
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2201-2210. PubMed ID: 30151601
[TBL] [Abstract][Full Text] [Related]
26. The optical coherence tomography angiography findings of rheumatoid arthritis patients taking hydroxychloroquine.
Ozek D; Onen M; Karaca EE; Omma A; Kemer OE; Coskun C
Eur J Ophthalmol; 2019 Sep; 29(5):532-537. PubMed ID: 30229672
[TBL] [Abstract][Full Text] [Related]
27. Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine.
Ulviye Y; Betul T; Nur TH; Selda C
Indian J Ophthalmol; 2013 Apr; 61(4):168-71. PubMed ID: 23685488
[TBL] [Abstract][Full Text] [Related]
28. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
29. Effect of stopping hydroxychloroquine therapy on the multifocal electroretinogram in patients with rheumatic disorders.
Adamptey B; Rudnisky CJ; MacDonald IM
Can J Ophthalmol; 2020 Feb; 55(1):38-44. PubMed ID: 31712033
[TBL] [Abstract][Full Text] [Related]
30. Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence.
Kellner S; Weinitz S; Kellner U
Br J Ophthalmol; 2009 Nov; 93(11):1444-7. PubMed ID: 19692385
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological and SD-OCT findings in patients receiving chloroquine therapy in relation to cumulative dosage and duration of treatment.
Bertoli F; Šuštar M; Jarc Vidmar M; Perovšek D; Brecelj J; Markelj Š; Jaki Mekjavić P; Šuput D; Tomšič M; Isola M; Battistella C; Lanzetta P; Hawlina M
Doc Ophthalmol; 2020 Aug; 141(1):1-14. PubMed ID: 31927702
[TBL] [Abstract][Full Text] [Related]
32. Hydroxychloroquine retinopathy.
Maturi RK; Folk JC; Nichols B; Oetting TT; Kardon RH
Arch Ophthalmol; 1999 Sep; 117(9):1262-3. PubMed ID: 10496407
[No Abstract] [Full Text] [Related]
33. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
Jayakar G; De Silva T; Cukras CA
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):15. PubMed ID: 35015028
[TBL] [Abstract][Full Text] [Related]
34. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
[TBL] [Abstract][Full Text] [Related]
35. Detection of the regression on hydroxychloroquine retinopathy in optical coherence tomography.
Turgut B; Turkcuoglu P; Serdar Koca S; Aydemir O
Clin Rheumatol; 2009 May; 28(5):607-9. PubMed ID: 19221829
[TBL] [Abstract][Full Text] [Related]
36. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
37. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
38. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
Missner S; Kellner U
Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255
[TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
Adam MK; Covert DJ; Stepien KE; Han DP
Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of toxic retinopathy caused by antimalarial medications with spectral domain optical coherence tomography.
Cabral RTS; Klumb EM; Couto MINN; Carneiro S
Arq Bras Oftalmol; 2019; 82(1):12-17. PubMed ID: 30403262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
